YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Key Points An Immunome insider sold 100,000 shares for $2.4 million based on weighted average prices on July 6, 2026 and July 7, 2026. The transaction represents 32% of the insider's total equity holdings in the company. The disposal was c…
Isaac Barchas, a director at Immunome, Inc. (NASDAQ:IMNM), executed a sale of 100,000 shares in a transaction disclosed in a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$2.4 million Shares sold (indirectly…
Shares of Immunome IMNM have witnessed a sharp increase over the past month, primarily driven by the growing investor confidence in the company's lead asset, varegacestat, and broader clinical progress. IMNM's Price Performance Shares of I…
The biotech industry has navigated the uncertain macroeconomic environment effectively so far this year. Upbeat first-quarter results, new drug approvals and positive clinical and pipeline developments have continued to drive momentum desp…
BOTHELL, Wash., May 27, 2026--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that members of Immunome’s management w…
Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. During the first quarter, the U.S. equity market declined…
Immunome, Inc. (NASDAQ:IMNM) is one of the 10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen. On April 29, Immunome, Inc. (NASDAQ:IMNM) reported the filing of a new drug application with the US Food and Drug Administ…
June S&P 500 E-Mini futures (ESM26) are trending up +0.46% this morning as investors shrugged off an exchange of fire between the U.S. and Iran and awaited the release of the key U.S. jobs report. The U.S. military said on Thursday that Ir…
Techne (TECH) came out with quarterly earnings of $0.53 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.56 per share a year ago. These figures are adjusted for non-recurring items. This q…
Exelixis (EXEL) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.62 per share a year ago. These figures are adjusted for non-recurring items. This…
CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to a loss of $1.58 per share a year ago. These figures are adjusted for non-recurring ite…
Key Points 9,438 shares were sold for a transaction value of ~$204,000 on April 2, 2026. This sale represented 30.02% of Higgins’s holdings at the time. All shares sold were held directly; 3,000 shares remain held indirectly after the sale…
Jack Higgins, Chief Scientific Officer of Immunome(NASDAQ:IMNM), reported the sale of 9,438 shares of common stock in an open-market transaction on April 2, 2026, as disclosed in the SEC Form 4 filing. Transaction summary Metric Value Shar…
On February 17, 2026, ENAVATE Sciences GP, LLC disclosed a buy of 157,800 shares of Zenas BioPharma(NASDAQ:ZBIO), an estimated $5.19 million trade based on quarterly average pricing. ENAVATE Sciences added 157,800 shares of Zenas BioPharma…
On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome(NASDAQ:IMNM), an estimated $37.30 million trade based on quarterly average pricing. What Happened According to its SEC filing dated February 17…
Immunome, Inc. (NASDAQ:IMNM) is one of the best cancer stocks to invest in now. On February 14, Immunome, Inc. (NASDAQ:IMNM) CEO and Chairman Clay Siegall reiterated heightened focus on building an oncology-focused pipeline centered on cel…
On February 17, 2026, Redmile Group disclosed a buy of 4,415,514 Nurix Therapeutics(NASDAQ:NRIX) shares, an estimated $63.43 million trade based on quarterly average pricing. What happened According to a Securities and Exchange Commission…
On February 17, 2026, Redmile Group disclosed a buy of 695,000 shares of Immunome(NASDAQ:IMNM), an estimated $12.20 million trade based on quarterly average pricing. What happened According to a February 17, 2026, SEC filing, Redmile Group…
Redmile Group disclosed a significant reduction in its Zymeworks(NASDAQ:ZYME) position in a February 17, 2026, SEC filing, selling an estimated $70.10 million in shares based on quarterly average pricing. What happened According to a Febru…
Redmile Group reported a purchase of 16,317 shares of Krystal Biotech(NASDAQ:KRYS) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.43 million based on quarterly average pricing. What happened According to a…
Redmile Group disclosed a buy of 1,316,390 shares of Scholar Rock Holding Corporation(NASDAQ:SRRK) in a February 17, 2026, SEC filing, with the estimated transaction value at $49.37 million based on quarterly average pricing. What happened…
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Shopify (SHOP) to Buy fr…
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Shopify (SHOP) to Buy fr…
Immunome, Inc. (NASDAQ:IMNM) is among the 14 best booming stocks to buy right now. The company’s shares are surging and have gained 48% in the last three months.Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now? Stock market…
Immunome, Inc. (NASDAQ:IMNM) is one of the stocks Jim Cramer offered insights on. When a caller inquired about the stock, Cramer stated: “This company’s losing so much money, I know, but it’s Dr. Siegall… So therefore, if you want to specu…
BOTHELL, Wash., January 06, 2026--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will prese…
(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Halozy…
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Thursday, Immunome's CEO, Clay B. Siegall,…
Immunome (IMNM [https://seekingalpha.com/symbol/IMNM]) has priced a public offering [https://seekingalpha.com/pr/20342088-immunome-announces-pricing-of-public-offering-of-common-stock] of 18.63 million shares at $21.50 per share. The compa…
VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways th…
The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.51%. December E-mini S&P futures (ESZ25) fell -0.…
Key Points A phase 3 study of varegacestat met its primary endpoint. The drug candidate could reduce the risk of disease progression or death in people with desmoid tumors by 84%. 10 stocks we like better than Immunome › Shares of Immunome…
The S&P 500 Index ($SPX) (SPY) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is down by -0.24%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -0.26%. December E-mini S&P futures (ESZ25) are down -0.18%, and Dec…
The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.51%. December E-mini S&P futures (ESZ25) fell -0.…
Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Monday. This is TheStreet’s Stock Market Today for Dec. 15, 2025. You can…